Zanoprima Lifesciences

About Zanoprima Lifesciences

Zanoprima Lifesciences Ltd is a UK-based company which was founded in 2014 by leading professionals and scientists from pharma and life sciences sectors. We are proud to introduce SyNic; the world’s first totally synthetic, high purity (typically 99.9%) (S)-Nicotine that is not obtained from any part of tobacco nor derived from a synthetic racemic mixture. Around 1.3 billion people in the world currently use tobacco products leading to severe adverse impact on health, our society and our environment. SyNic, a pure (typically 99.9%) synthetic (S)-Nicotine, is a substantially cleaner source of nicotine for tobacco substitution, nicotine replacement therapy and medicinal nicotine products. SyNic contains no toxins or carcinogens that are found in tobacco-based Nicotine. Our suite of patented game-changing innovations around synthetic (S)-Nicotine and its applications facilitate the movement towards a tobacco-free world. Our production of (S)-Nicotine is underpinned by the adoption of “Green Chemistry” principles to minimize the environmental impacts of nicotine production. Our next-generation tobacco free applications include: Znus: Tobacco-free white snus Znus is completely sodium free and tobacco free that makes it potentially a safer and less harmful nicotine product. The proprietary formulae contain buffered free nicotine. A revolution in e-cigarettes Our patented protonated (S)-Nicotine e-liquid derived from SyNic for e-cigarettes is without any potentially harmful ingredients such as organic acids and propylene glycol. Next-gen chewing gum and lozenges Zanoprima chewing gums and lozenges offer unique characteristics, providing an instant burst and sustained release of nicotine that users seek. Transdermal patches, HNB and more… We are currently working on a completely tobacco free heated nicotine product as well as skin friendly transdermal patches for Alzheimer’s and dementia.

View contact profiles from Zanoprima Lifesciences